Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma exchange for refractory Kawasaki disease.

Literature DB >> 14986117

Plasma exchange for refractory Kawasaki disease.

Tomoyuki Imagawa¹, Masaaki Mori, Takako Miyamae, Shuichi Ito, Tomoko Nakamura, Kiyoshi Yasui, Hirokazu Kimura, Shumpei Yokota.

Abstract

Entities: Disease

Mesh：

Year: 2004 PMID： 14986117 DOI： 10.1007/s00431-003-1267-y

Source DB: PubMed Journal: Eur J Pediatr ISSN： 0340-6199 Impact factor: 3.183

× No keyword cloud information.

6 in total

1. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.

Authors: M Mori; T Imagawa; K Yasui; A Kanaya; S Yokota
Journal: J Pediatr Date: 2000-08 Impact factor: 4.406

2. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.

Authors: T Matsubara; S Furukawa; K Yabuta
Journal: Clin Immunol Immunopathol Date: 1990-07

3. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors: T Kawasaki
Journal: Arerugi Date: 1967-03

4. Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study.

Authors: K Arjunan; S R Daniels; R A Meyer; D C Schwartz; H Barron; S Kaplan
Journal: J Am Coll Cardiol Date: 1986-11 Impact factor: 24.094

5. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.

Authors: D A Wright; J W Newburger; A Baker; R P Sundel
Journal: J Pediatr Date: 1996-01 Impact factor: 4.406

6. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.

Authors: D Y Leung; R S Cotran; E Kurt-Jones; J C Burns; J W Newburger; J S Pober
Journal: Lancet Date: 1989-12-02 Impact factor: 79.321

6 in total

11 in total

1. Infliximab treatment for pediatric refractory Kawasaki disease.

Authors: Laura L Blaisdell; Jennifer A Hayman; Adrian M Moran
Journal: Pediatr Cardiol Date: 2011-07-20 Impact factor: 1.655

Review 2. Treatment Options for Resistant Kawasaki Disease.

Authors: Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal: Paediatr Drugs Date: 2018-02 Impact factor: 3.022

3. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.

Authors: Satoru Iwashima; Mituaki Kimura; Takamichi Ishikawa; Takehiko Ohzeki
Journal: Clin Drug Investig Date: 2011 Impact factor: 2.859

4. Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease.

Authors: Eisuke Suganuma; Fumio Niimura; Shinichi Matsuda; Toshiko Ukawa; Hideaki Nakamura; Kaori Sekine; Masahiko Kato; Yuji Aiba; Yasuhiro Koga; Kuniyoshi Hayashi; Osamu Takahashi; Hiroyuki Mochizuki
Journal: Pediatr Res Date: 2016-12-20 Impact factor: 3.756

5. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas.

Authors: Fernanda Falcini; Serena Capannini; Donato Rigante
Journal: Pediatr Rheumatol Online J Date: 2011-07-20 Impact factor: 3.054

6. Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease.

Authors: Kei Takahashi; Toshiaki Oharaseki; Tomokazu Nagao; Yuki Yokouchi; Hitomi Yamada; Noriko Nagi-Miura; Naohito Ohno; Tsutomu Saji; Tomio Okazaki; Kazuo Suzuki
Journal: Pediatr Rheumatol Online J Date: 2011-09-29 Impact factor: 3.054

7. KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease.

Authors: Fenglei Zheng; Yijing Tao; Jingjing Liu; Zhimin Geng; Ying Wang; Yujia Wang; Songling Fu; Wei Wang; Chunhong Xie; Yiying Zhang; Fangqi Gong
Journal: J Inflamm Res Date: 2021-03-05